The largest database of trusted experimental protocols

Silencer select validated sirna for abcc4 silencing

Manufactured by Thermo Fisher Scientific

Silencer Select Validated siRNA for ABCC4 silencing is a laboratory product designed to reduce the expression of the ABCC4 gene in cell-based experiments. It provides a pre-designed and validated small interfering RNA (siRNA) sequence to target and silence the ABCC4 gene.

Automatically generated - may contain errors

2 protocols using silencer select validated sirna for abcc4 silencing

1

ABCC4 Gene Silencing in AML Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Silencer Select Validated siRNA for ABCC4 silencing (Ambion, Austin, TX) and the Silencer Select Negative Control #1 siRNA were used in all experiments. Cells were transfected with ABCC4 siRNA using Nucleofector II and nucleofector Kit T (Amaxa), according to the manufacturer's protocol. OCI‐AML3 cells (3 × 106) were treated with 100 μL reagent of solution T for each sample, using 1–3 μg of siRNA for each sample to optimize the best silencing effect. To evaluate ABCC4 suppression (see below), total RNA was extracted using TRIzol (Invitrogen) and analyzed by real‐time polymerase chain reaction (PCR) at variable times posttransfection. cDNA was synthesized by using a primer set designed to amplify exon 3, which encompasses the siRNA cleavage point. In each sample, the copy number of ABCC4 relative to glyceraldehydes‐3‐phosphate dehydrogenase (GAPDH) expression was calculated as follows: 2^dCt [dCt = Ct(GAPDH)‐Ct(ABCC4)]. Protein expression of ABCC4 was determined by western blot as described above.
+ Open protocol
+ Expand
2

Validating ABCC4 siRNA Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Silencer Select Validated siRNA for ABCC4 silencing (Ambion) and the Silencer Select Negative Control #1 siRNA were used in all experiments. Cells were transfected with ABCC4 siRNA using Nucleofector II and nucleofector Kit T (Amaxa), according to the manufacturer’s protocol. OCI-AML3 cells (3×106) were treated with 100 μl reagent of solution T for each sample, using 1–3 μg of siRNA for each sample to optimize the best silencing effect. To evaluate ABCC4 suppression (see below), total RNA was extracted using TRIzol (Invitrogen) and analysed by real-time PCR at variable times post-transfection. cDNA was synthesized by using a primer set designed to amplify exon 3 which encompasses the siRNA cleavage point. In each sample, the copy number of ABCC4 relative to glyceraldehydes-3-phosphate dehydrogenase (GAPDH) expression was calculated as follows: 2^dCt [dCt=Ct(GAPDH)-Ct(ABCC4)]. Protein expression of ABCC4 was determined by western blot as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!